The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYourgene Share News (YGEN)

Share Price Information for Yourgene (YGEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.85
Bid: 11.50
Ask: 12.20
Change: -0.40 (-3.27%)
Spread: 0.70 (6.09%)
Open: 12.25
High: 12.25
Low: 11.75
Yest. Close: 12.25
YGEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Yourgene awarded PHE diagnostics framework agreement

Mon, 19th Apr 2021 08:49

(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.
The AIM-traded firm said the award was for the four-lot tender for its 'Clarigene' SARS-CoV-2 assay, and its Manchester-based Covid-19 testing service.

It said the framework was appointing suppliers to framework agreements for four lots.

Lot 1 was the first to be announced, and covered the supply of in-vitro diagnostic medical devices and associated services, including for the company's Clarigene SARS-CoV-2 PCR assay and the associated clinical laboratory testing services delivered through Yourgene Genomic Services.

The term of the framework agreement for the lot, and for each subsequent lot, if awarded, would be for an initial two years with options to extend by up to a further two years.

Yourgene said Lot 1 is a £3bn tender, to be satisfied by multiple successful bidders.

Under the National Microbiology Framework, participating public health authorities across the UK could use call-off contracts to procure goods and testing services from Yourgene under such lots as it is in receipt of a framework agreement.

There was no guarantee, however, that such contracts would be forthcoming, nor as to the quantum of any potential call-off contracts.

"We welcome the opportunity to work with PHE and its sister organisations across the NHS, DHSC and in Wales, Scotland and Northern Ireland to offer our Clarigene SARS-CoV-2 PCR assay, and our accredited lab testing services, to contain Covid-19 in the near-term and to participate in putting in place a robust testing infrastructure post-pandemic," said chief executive officer Lyn Rees.

"Yourgene considers that the successful framework award, for which there was a competitive tender process, lends significant credibility to the Clarigene product and to the company's Covid testing services.

"More broadly, we expect the award to support business development outside the scope of this agreement with a growing network of commercial partners, addressing privately funded testing in healthcare and workplace settings."

At 1622 BST, shares in Yougene Health were up 7.33% at 16.10p.

More News

IN BRIEF: Yourgene Health secures agreement for Ranger technology

IN BRIEF: Yourgene Health secures agreement for Ranger technology

21 Jun 21 21:26

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

18 Jun 21 13:23

Yourgene awarded supply contract with NHS Wales

(Sharecast News) - Molecular diagnostics group Yourgene Health has secured a contract to supply its Elucigene DPYD testing kits to NHS Wales.

18 Jun 21 09:17

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

IN BRIEF: Yourgene Health signs deal with US precision medicine firm

9 Jun 21 14:09

Yourgene inks agreement with US-based precision medicine company

(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.

9 Jun 21 09:58

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

19 May 21 19:33

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

18 May 21 19:15

MyHealthChecked seals second Covid-19 test contract with Boots

MyHealthChecked seals second Covid-19 test contract with Boots

17 May 21 10:56

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

29 Apr 21 14:34

IN BRIEF: Yourgene wins two tenders for national framework contract

IN BRIEF: Yourgene wins two tenders for national framework contract

26 Apr 21 14:22

Yourgene awarded two more PHE framework agreements

(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.

26 Apr 21 10:56

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

19 Apr 21 14:10

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

19 Apr 21 11:44

Yourgene awarded PHE diagnostics framework agreement

(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.

19 Apr 21 08:49

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

Yourgene signs Covid test deal with MyHealthChecked to supply Boots

6 Apr 21 15:40

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.